Compare Manali Petrochem with Similar Stocks
Stock DNA
Petrochemicals
INR 754 Cr (Micro Cap)
11.00
13
1.09%
-0.18
4.52%
0.69
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Manali Petrochemicals Ltd is Rated Sell
Manali Petrochemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Manali Petrochemicals Ltd Falls to 52-Week Low of Rs.43.82
Manali Petrochemicals Ltd, a micro-cap player in the petrochemicals sector, recorded a fresh 52-week low of Rs.43.82 on 16 Mar 2026, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures in its market performance and valuation metrics.
Read full news article Announcements 
Manali Petrochemicals Limited - Other General Purpose
03-Dec-2019 | Source : NSEManali Petrochemicals Limited has submitted to the Exchange a copy of details of Related Party Transactions pursuant toáRegulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019.á
Manali Petrochemicals Limited - Press Release
13-Nov-2019 | Source : NSEManali Petrochemicals Limited has informed the Exchange regarding a press release dated November 12, 2019, titled "Q2 RESULTS".
Manali Petrochemicals Limited - Trading Window
25-Sep-2019 | Source : NSEManali Petrochemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Corporate Actions 
No Upcoming Board Meetings
Manali Petrochemicals Ltd has declared 10% dividend, ex-date: 08 Sep 25
Manali Petrochemicals Ltd has announced 5:8 stock split, ex-date: 28 Sep 06
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 4 Schemes (0.01%)
Held by 25 FIIs (0.29%)
Sidd Life Sciences Private Limited (38.28%)
Mercantile Ventures Limited (2.39%)
39.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -0.41% vs 5.70% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 277.02% vs 26.57% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 2.56% vs -17.62% in Sep 2024
Growth in half year ended Sep 2025 is 145.76% vs -11.69% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 9.44% vs -14.09% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 445.81% vs 3.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -13.10% vs -12.30% in Mar 2024
YoY Growth in year ended Mar 2025 is 52.58% vs -62.09% in Mar 2024







